Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557)
Zapisane w:
| Wydane w: | Alzheimer's & Dementia vol. 21 (Dec 1, 2025) |
|---|---|
| 1. autor: | |
| Kolejni autorzy: | , , |
| Wydane: |
John Wiley & Sons, Inc.
|
| Hasła przedmiotowe: | |
| Dostęp online: | Citation/Abstract Full Text - PDF |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Napisz pierwszy komentarz!